ConductScience.org, home
actinic keratosis
API referenceFor AI assistants

Disease · MONDO_0005173

Comparisons in its trials74

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

1 to 20 of 74

Download this page as JSON
ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
Ingenol Mebutate Gel vs Vehicle: deaths from any cause0 of 5490 of 176725NCT02361216Trial comparisons
Ingenol Mebutate Gel vs Vehicle: serious adverse events8 of 5492 of 176725NCT02361216Trial comparisons
MAL 16.8% Cream vs MAL Vehicle Cream: deaths from any cause0 of 3640 of 193557NCT04085367Trial comparisons
MAL 16.8% Cream vs MAL Vehicle Cream: serious adverse events5 of 3641 of 193557NCT04085367Trial comparisons
Ingenol Mebutate vs Imiquimod: Number of Participants With Complete Clearance of AK Lesions After Last Treatment168 of 240192 of 245485NCT01926496Trial comparisons
Ingenol Mebutate vs Imiquimod: Number of Participants With Complete Clearance of AK Lesions at 12 Months70 of 240108 of 245485NCT01926496Trial comparisons
Ingenol Mebutate vs Imiquimod: Number of Participants With Partial Clearance of AK Lesions195 of 240210 of 245485NCT01926496Trial comparisons
KX2-391 Ointment 1% vs Placebo: Number of Participants With Clinically Significant Safety Observations- Physical Examination0 of 1750 of 176351NCT03285477Trial comparisons
KX2-391 Ointment 1% vs Placebo: Number of Participants With Clinically Significant Safety Observations- Vital Signs0 of 1750 of 176351NCT03285477Trial comparisons
KX2-391 Ointment 1% vs Placebo: deaths from any cause0 of 1751 of 176351NCT03285477Trial comparisons
KX2-391 Ointment 1% vs Placebo: Number of Participants With Clinically Significant Safety Observations- Electrocardiograms (ECGs)0 of 1750 of 176351NCT03285477Trial comparisons
KX2-391 Ointment 1% vs Placebo: serious adverse events1 of 1752 of 176351NCT03285477Trial comparisons
KX2-391 Ointment 1% vs Placebo: Number of Participants With Clinically Significant Safety Observations- Physical Examination0 of 1780 of 173351NCT03285490Trial comparisons
KX2-391 Ointment 1% vs Placebo: Number of Participants With Clinically Significant Safety Observations- Vital Signs0 of 1780 of 173351NCT03285490Trial comparisons
KX2-391 Ointment 1% vs Placebo: deaths from any cause0 of 1780 of 173351NCT03285490Trial comparisons
KX2-391 Ointment 1% vs Placebo: Number of Participants With Clinically Significant Safety Observations- Electrocardiograms (ECGs)0 of 1780 of 173351NCT03285490Trial comparisons
KX2-391 Ointment 1% vs Placebo: serious adverse events1 of 1784 of 173351NCT03285490Trial comparisons
PEP005 Gel, 0.015% vs Vehicle Gel: Partial Clearance of AKs at Week 11130 of 167109 of 162329NCT01541553Trial comparisons
PEP005 Gel, 0.015% vs Vehicle Gel: Complete Clearance of AKs at Week 11101 of 16780 of 162329NCT01541553Trial comparisons
PEP005 Gel, 0.015% vs Vehicle Gel: serious adverse events7 of 1674 of 162329NCT01541553Trial comparisons

diseases-2026-09-18-0.1.0

Next page

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0005173/comparisons

API referenceFor AI assistants